The glucose monitoring device known as K’Watch has begun clinical testing. This is the last stage to be completed before certification and distribution to retail outlets. The apparatus is not entirely non-invasive. However, it does not require the removal of blood.
There is a great deal of speculation that brand new sensors will become available in the year 2022. As opposed to the current generation of activity trackers and smartwatches, these will supposedly be able to monitor your glucose levels in a way that does not require any invasive testing by using green light technology at longer wavelengths. It remains to be seen whether or not we genuinely observe this.
On the other hand, a glucose tracking wrist bracelet developed by the French health technology business PKvitality is almost ready for release. This smartwatch costs $199 and can check your glucose levels without requiring you to draw any blood from your arm.
Diabetes is quickly expanding and now affects 415 million people, or one in eleven people worldwide. It is responsible for millions of fatalities each year and is a leading cause of blindness, kidney failure, heart disease, stroke, and the amputation of lower limbs.
It is widely held that the holy grail of diabetes management is glucose monitoring that does not include any intrusive procedures. Patients with diabetes currently have no reliable alternatives to the method of tracking glucose that involves piercing the skin, even though numerous companies have attempted but failed to provide a solution. Some people with diabetes still rely on pen and paper to record their blood sugar readings and other data. We are getting close to the year 2022, and that is not acceptable!
This innovative biosensor is responsible for its operation. Instead of drawing blood samples, the device performs its function by “tasting” the surface of the skin. The K’Watch Glucose was one of approximately two dozen devices that were selected as winners of the show’s Best of Innovation Award when it was first shown off at CES 2017 at the beginning of the year.
Their patented technology consists of biosensors that can analyze interstitial fluid’s biochemical components through microneedles to probe the tissue. Even while the user will feel the mild pressure of the probe when it presses against their skin, they will not feel any discomfort because the sensor never actually makes contact with any nerves or blood vessels. It actually adheres to the skin, which is one of the reasons why it stays in place so well.
K’apsul is the name given to the container that contains the company’s technology. Readings are reportedly obtained at regular intervals of 5 minutes by default, as stated on the support website. One can use one of them for up to a week before it needs to be replaced, during which time you are permitted to take an unlimited number of measurements. Users will likely have the ability to select the time gap between measurements that are recorded in between each one.
The results are shown on the screen of the K’Watch Glucose and are also synchronized with the companion software for either iOS or Android. In addition, the device can send notifications to its users to remind them to check their blood glucose levels. You also get some of the more conventional services for monitoring your fitness, such as the number of steps you take, the distance you travel, your heart rate, how well you sleep, and the number of calories you burn.
PKvitality stated in a press release that “K’Track Glucose will be the first accurate non-blood-based glucose meter to be placed directly into a smartwatch.”
“It blends the sophistication and convenience of conventional activity trackers with the potentially life-changing information of a medical device,” the company says.
The technology is embodied not just in the shape of a watch but also in the form of an armband as well. This more expensive version, which is known as the K’Watch Athlete, gives athletes the ability to monitor the level of lactic acid in their bodies in real-time. In addition, K’Watch Athlete makes it possible to monitor glucose levels continuously.
Availability and Pricing of The Product
Once it is released, the K’Watch Glucose will be available for purchase at a price of $199, and a month’s supply of K’apsul will cost $99. The price for the K’Track Athlete has not been determined at this time.
The medical device has only recently been put through its first clinical trial, which will involve 35 patients suffering from diabetes types 1 and 2 and will last until June 2022. This task aims to evaluate how well the integrated continuous glucose monitoring (iCGM) standards of FDA Class II are being met in terms of accuracy. In spite of our best efforts, we will not be able to make this available to you in the coming weeks at any of our retail locations.
If all goes according to plan, the introduction of K’Watch Glucose will take place between the end of 2022 and the beginning of 2023. Because different regions have different requirements for necessary medical certifications, each country will have different release dates. More than ten million euros have been invested in the project, which ought to, at the very least, make it easier to bring it to a successful conclusion. The European Commission made a grant, and an equity investment in this company through a fund called the European Innovation Council (EIC), which contributed some of the funds.